Fred Hutch spinout raises $6M to build out team, immune system technology

Ozette is not the first company to come out of the Hutch and develop a technology that studies the immune system.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.